As of Feb 03, 2025, Quest Diagnostics Incorporated's discount rate is 5.92%. This rate is determined based on the weighted average cost of capital (WACC) and the cost of equity, factoring in Quest Diagnostics Incorporated's capital structure and risk profile.
Quest Diagnostics Incorporated's WACC as of Feb 03, 2025, is 5.92%. This value is calculated by blending the cost of debt and cost of equity, reflecting the company’s overall cost of financing its operations.
Quest Diagnostics Incorporated's cost of equity is 8.6%, as of Feb 03, 2025. This is the return that shareholders expect based on the stock's risk level and market conditions, used to calculate the discount rate for valuing future cash flows.